Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TAL1 antibody (CF®405S)

This Mouse Monoclonal antibody specifically detects TAL1 in IHC, FACS, ChIP, IHC (fp) and EMSA. It exhibits reactivity toward Human.
Catalog No. ABIN7660525

Quick Overview for TAL1 antibody (CF®405S) (ABIN7660525)

Target

See all TAL1 Antibodies
TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))

Reactivity

  • 103
  • 39
  • 27
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
Human

Host

  • 86
  • 27
Mouse

Clonality

  • 87
  • 26
Monoclonal

Conjugate

  • 58
  • 8
  • 7
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TAL1 antibody is conjugated to CF®405S

Application

  • 70
  • 44
  • 20
  • 14
  • 13
  • 11
  • 9
  • 9
  • 9
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Flow Cytometry (FACS), Chromatin Immunoprecipitation (ChIP), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp)), Electrophoretic Mobility-Shift Assay (EMSA)

Clone

BTL73
  • Purpose

    Tal1(BTL73), CF405S conjugate

    Characteristics

    Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase IIHLH transcription factors. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant human full-length TAL1 protein

    Isotype

    IgG1, kappa
  • Application Notes

    ELISA: For coating, order antibody without BSA, Western blot 0.5-1.0 μg/mL, Optimal dilution for a specific application should be determined.. Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody

    Comment

    Positive Control: A549 xenograft.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))

    Alternative Name

    Tal1

    Background

    Synonyms: bHLHa17, Class A basic helix-loop-helix protein 17, OTTHUMP00000009563, OTTHUMP00000009564, SCL, STEM CELL LEUKEMIA HEMATOPOIETIC TRANSCRIPTION FACTOR, Stem cell protein, T cell acute lymphocytic leukemia 1, T cell acute lymphocytic leukemia 1 protein, T cell acute lymphocytic leukemia 1 protein, T cell leukemia/lymphoma 5 protein, T-cell acute lymphocytic leukemia protein 1, T-cell leukemia/lymphoma protein 5, Tal 1 product, TAL 1 protein, TAL bHLH transcription factor 1 erythroid differentiation factor, TAL-1

    Gene Symbol: TAL1

    Molecular Weight

    42 kDa

    Gene ID

    6886

    UniProt

    P17542

    Pathways

    Stem Cell Maintenance
You are here:
Chat with us!